Compared to other antihypertensive medications, the risk of nightmares was higher in β‐blocker users but did not reach statistical significance (RR 2.80, 95% CI [0.47–17.41], I 2 = 0%, two studies) (Figure 9 ).
← all excerpts
β-Blockers and risk of neuropsychiatric disorders: A systematic review and meta-analysis.
3
—
—
The sentences
However, the findings suggest a possible trend towards increased somnolence, particularly with specific β‐blockers, warranting further investigation into this side effect.
While less frequently reported, nightmares showed a trend towards increased risk in patients using β‐blockers.